Trial NCT04543188

View at ClinicalTrials.gov 
Org. Study IDs: C4471001
Secondary IDs: 2022-003184-23

Last trial update was posted on 2024-04-03

MeSH Interventions

Midazolam

MeSH Conditions

Brain Neoplasms Carcinoma, Non-Small-Cell Lung Melanoma Neoplasms

Other Conditions

Brain Neoplasms, Primary Malignant Melanoma Malignant Neoplasms

Stopping Reasons

Pfizer has made an internal business decision to not continue further development of PF-07284890. This decision was not due to major safety concerns or requests from any regulatory authorities.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID